Oral probiotic extracellular vesicle therapy mitigates Influenza A Virus infection via blunting IL-17 signaling
Most Cited Paper
in Pediatric health and respiratory diseases
18 Months Post-Publication
Class of 2026
“Oral probiotic extracellular vesicle therapy mitigates Influenza A Virus infection via blunting IL-17 signaling”
A research intelligence initiative by Pepkio
pri.pepkio.com
Topics
probiotic extracellular vesicles · Influenza A virus · IL-17 signaling · Limosilactobacillus reuteri · LrEVs · intestinal mucosal damage · Microbiome composition · Short-chain fatty acids · miR-4239 · IL-17A · Th17 cell differentiation · IL-17-producing ILCs · oral administration · Gut-lung axis · Anti-inflammatory mechanism · FISH analysis · H1N1 influenza virus · gut-lung immunity
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Pediatric health and respiratory diseases Papers, Class of 2026. https://pri.pepkio.com/top-papers/pediatric-health-and-respiratory-diseases/2026. Accessed 2026-08-20. Methodology Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459